LATAM OTC Results Round-Up: Mexico's Genomma Lab, Brazil's Hypera

Genomma enjoys broad-based growth in 2018, while NPD investments pay off for Hypera.

Coins
• Source: Shutterstock

Mexico’s Genomma Lab Internacional SAB de CVreported OTC sales up by 14.2% to MXN6.07bn ($314m) in 2018, as turnover improved at a double-digit rate in all three of its reporting regions.

The 14.2% growth rate had been thanks to “key trade initiatives implemented across the regions during 2018 to enhance point of sale execution and visibility,” the firm noted.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Earnings

More from Business